Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Awarded Patent for Optics in I-CORE Technology

NEW YORK, June 26 -Cepheid said today it had won a patent for the optical detection system used with its I-CORE technology.


The patent, No. 6,565,815, covers aspects of the optics in the I-CORE system that allow accurate detection of multiple DNA molecules at once in a single reaction chamber.


The I-CORE, or Integrated Cooling/heating Optical Reaction system, is designed for the amplification and detection of nucleic acids, and is integrated into the company's Smart Cycler and GeneXpert systems.


Cepheid said it has nine other issued patents for its technology.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.